Juan Antonio Requena-Ibáñez, Kristine Mørk Kindberg, Carlos G. Santos-Gallego, M. Urooj Zafar, Juan J. Badimon
Springer Nature ·
2025-06-04
· DOI 10.1007/s10557-025-07723-z
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Juan Antonio Requena-Ibáñez, Kristine Mørk Kindberg, Carlos G. Santos-Gallego, M. Urooj Zafar, Juan J. Badimon. Sotagliflozin: Two Birds with One Stone?. // Cardiovascular Drugs and Therapy. – 2025. – DOI: 10.1007/s10557-025-07723-z. – URL: https://doi.org/10.1007/s10557-025-07723-z
Juan Antonio Requena-Ibáñez, Kristine Mørk Kindberg, Carlos G. Santos-Gallego, M. Urooj Zafar, & Juan J. Badimon (2025). Sotagliflozin: Two Birds with One Stone?. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-025-07723-z
Juan Antonio Requena-Ibáñez, et al. “Sotagliflozin: Two Birds with One Stone?.” Cardiovascular Drugs and Therapy, 2025. doi:10.1007/s10557-025-07723-z.
@article{RequenaIbez2025,
title = {Sotagliflozin: Two Birds with One Stone?},
author = {Requena-Ibáñez, Juan Antonio and Kindberg, Kristine Mørk and Santos-Gallego, Carlos G. and Zafar, M. Urooj and Badimon, Juan J.},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
doi = {10.1007/s10557-025-07723-z},
url = {https://doi.org/10.1007/s10557-025-07723-z}
}